Gw Pharmaceuticals Plc (GWPH) Inventory Turnover Ratio, from first quarter 2021 to first quarter 2020, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Gw Pharmaceuticals Plc  (NASDAQ: GWPH)
 

Gw Pharmaceuticals Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Gw Pharmaceuticals Plc's inventory turnover ratio, the ratio that measures Gw Pharmaceuticals Plc's ability to manage its supply chain, sequentially decreased to 3.56 in the first quarter 2021, which does not come as a surprise, as the Gw Pharmaceuticals Plc continue to experience headwinds, which also impact its supply chain. Gw Pharmaceuticals Plc's average inventory processing period in the Mar 31 2021 quarter, has increased to 103 days, from 95 days, in the Dec 31 2020 quarter.

Within Healthcare sector 127 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2021, to 1976, from total ranking in the fourth quarter 2020 at 1978.

GWPH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Gw Pharmaceuticals Plc Market Share?

What is Inventory Turnover Ratio?




GWPH Inventory Turnover Ratio (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Inventory Growth 73.52 % 175.42 % 38.25 % 64.97 % -8.2 %
Y / Y Cost of Sales Growth 9.64 % 42.77 % -6.32 % 31.54 % 109.88 %
Inventory Turnover Ratio (TTM) 3.56 3.83 4.52 5.03 5.52
GWPH's Total Ranking # 1976 # 1978 # 1978 # 1958 # 1982
Average inventory processing period 103 95 81 73 66
Seq. Inventory Growth -29.22 % 40.99 % -2.84 % 78.96 % 12.35 %
Seq. Cost of Sales Growth 13.32 % 36.46 % -12.32 % -19.14 % 47.56 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 40
Healthcare Sector # 128
Overall Market # 1976

Inventory Turnover Ratio Statistics
High Average Low
5.52 4.19 3.47
(Mar 31 2020)   (Mar 31 2019)




Financial Statements
Gw Pharmaceuticals Plc's Inventories $ 10 Millions Visit GWPH's Balance sheet
Gw Pharmaceuticals Plc's Cost of Revenues TTM $ 39 Millions Visit GWPH's Income Statement
What are GWPH's Sales? Visit GWPH's Sales by Segment

Other Inventory Turnover Ratios
Gw Pharmaceuticals Plc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
GWPH's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for GWPH's Competitors
Inventory Turnover Ratio for GWPH's Suppliers
Inventory Turnover Ratio for GWPH's Customers

You may also want to know
GWPH's Sales Growth Rates GWPH's Pe Price to earnings ratio GWPH's Receivables Turnover Ratio GWPH's Stock Quote
GWPH's Net Income Growth Rates GWPH's Ps Price to Sales ratio GWPH's Sales per Employee GWPH's Asset Turnover Ratio
GWPH's Net Margin GWPH's Pb Price to Book ratio GWPH's Financial Strength Ratios GWPH's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2021, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2021 Inventories at quarter ending Mar 31 2021
Natera Inc   10.02 $ 205.667  Millions$ 21  Millions
National Vision Holdings Inc   10.01 $ 1,152.094  Millions$ 115  Millions
Polarityte Inc   9.94 $ 6.073  Millions$ 1  Millions
Fortress Biotech Inc   9.87 $ 14.692  Millions$ 1  Millions
Biotricity Inc   9.67 $ 1.871  Millions$ 0  Millions
Scienture Holdings Inc   9.64 $ 12.522  Millions$ 1  Millions
Cryo cell International Inc   9.05 $ 9.167  Millions$ 1  Millions
Opko Health Inc   8.74 $ 1,040.441  Millions$ 119  Millions
Charles River Laboratories International inc   8.69 $ 1,584.381  Millions$ 182  Millions
Veracyte Inc   8.32 $ 46.745  Millions$ 6  Millions
Eargo Inc   8.27 $ 23.514  Millions$ 3  Millions
Grapefruit Usa Inc   8.11 $ 3.360  Millions$ 0  Millions
Incyte Corporation  8.02 $ 133.229  Millions$ 17  Millions
Biora Therapeutics Inc   7.88 $ 89.097  Millions$ 11  Millions
Kewaunee Scientific Corporation  7.67 $ 123.476  Millions$ 16  Millions
Perspective Therapeutics Inc   7.18 $ 4.776  Millions$ 1  Millions
Harmony Biosciences Holdings inc   7.06 $ 26.189  Millions$ 4  Millions
Smiledirectclub Inc   6.93 $ 195.036  Millions$ 28  Millions
Ufp Technologies Inc   6.84 $ 135.225  Millions$ 20  Millions
Enzo Biochem Inc  6.72 $ 60.831  Millions$ 9  Millions
Lifemd Inc   6.67 $ 9.352  Millions$ 1  Millions
Retractable Technologies Inc  6.52 $ 59.261  Millions$ 9  Millions
Steris Plc  6.31 $ 1,766.235  Millions$ 280  Millions
Avita Medical Inc   6.24 $ 4.769  Millions$ 1  Millions
Patterson Companies Inc   6.20 $ 4,708.936  Millions$ 759  Millions
Avid Bioservices Inc   6.17 $ 66.561  Millions$ 11  Millions
Avantor Inc   5.99 $ 4,468.800  Millions$ 746  Millions
Carlisle Companies Incorporated  5.94 $ 2,902.000  Millions$ 489  Millions
Catalent Inc   5.92 $ 2,510.100  Millions$ 424  Millions
Inogen Inc   5.74 $ 167.243  Millions$ 29  Millions

Date modified: 2026-09-08T15:10:15+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.